Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Sunquest Lauded by Frost & Sullivan for Driving Efficiency and Compliance with Its Differentiated Molecular Laboratory Information Management System 2021-03-02 22:00
Global Cord Blood Corporation Announces Receipt of Unsolicited Non-Binding Acquisition Proposal 2021-03-02 20:00
Merck and GPHL Collaborate on Business Innovation and Development in the Greater Bay Area 2021-03-02 18:12
Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX® (Sumatriptan Nasal Spray, 20 mg) 2021-03-02 16:01
CMAB Biopharma Congratulates QureBio on FDA Clearance of IND Application for Claudin18.2/PD-L1 Bispecific Antibody 2021-03-02 13:43
Kazia Licenses Cantrixil, a Clinical-stage, First-in-class Ovarian Cancer Drug Candidate, to Oasmia Pharmacetical AB 2021-03-02 07:00
INOVIO Announces Positive Results from REVEAL 1, a Phase 3 Pivotal Trial Evaluating VGX-3100, its DNA-based HPV Immunotherapy for the Treatment of High-grade Precancerous Cervical Dysplasia Caused by HPV-16 and/or HPV-18 2021-03-02 05:05
China Biologic Announces Shareholders' Approval of Merger Agreement 2021-03-01 21:00
Medilink Therapeutics Raises $50 Million in Series A Financing To Accelerate Next-Generation Conjugated Drugs Research & Development 2021-03-01 19:50
CARsgen Therapeutics Receives Orphan Medicinal Product Designation from the European Medicines Agency for CT041 CLDN18.2 CAR T Cells for the Treatment of Gastric Cancers 2021-03-01 19:00
Merck Builds on Leadership in Head and Neck Cancer Through Worldwide Licensing Agreement with Debiopharm for Pivotal-Stage Xevinapant 2021-03-01 18:48
Avalon SteriTech and SoftBank Robotics Group Launch New Joint Venture to Develop and Promote Innovative Public Healthcare and Hygiene Solutions 2021-03-01 13:00
Sciwind's Investigational New Drug Approved for NASH Trial 2021-03-01 09:00
Innovent Announces First Patient Outside China Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody 2021-03-01 08:23
Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index 2021-03-01 08:00
Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index 2021-03-01 08:00
Alterity to present at the 7th International Congress of Multiple System Atrophy 2021-02-26 20:45
Debiopharm And Genome & Company Join Forces To Create New Highly Specific Therapies For Cancer Patients 2021-02-26 19:14
Biocytogen announces acquisition of a third Beacon Optofluidic system to support expanding Antibody Discovery Platform 2021-02-25 23:45
Genome & Company and Debiopharm Join Forces To Create New Highly Specific Therapies for Cancer Patients 2021-02-25 07:00
1 256 257 258 259 260 451